Fondaparinux sodium and Heparin-induced thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Heparin-induced thrombocytopenia is reported as a side effect among people who take Fondaparinux sodium (fondaparinux sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Thrombosis.

The phase IV clinical study analyzes which people have Heparin-induced thrombocytopenia when taking Fondaparinux sodium. It is created by eHealthMe based on reports of 930 people who have side effects when taking Fondaparinux sodium from the FDA, and is updated regularly.

What is Fondaparinux sodium?

Fondaparinux sodium has active ingredients of fondaparinux sodium. eHealthMe is studying from 940 Fondaparinux sodium users. Check the latest studies of Fondaparinux sodium.

What is Heparin-induced thrombocytopenia?

Heparin-induced thrombocytopenia is found to be associated with 391 drugs and 550 conditions by eHealthMe. Check the latest studies of Heparin-induced thrombocytopenia.

On Jul, 20, 2026

930 people reported to have side effects when taking Fondaparinux sodium.
Among them, 43 people (4.62%) have Heparin-induced thrombocytopenia.

Could Fondaparinux sodium cause Heparin-induced thrombocytopenia?

Among these 43 people:

How long have people been on Fondaparinux sodium when they have Heparin-induced thrombocytopenia? *

What is the gender of people who have Heparin-induced thrombocytopenia when taking Fondaparinux sodium? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Heparin-induced thrombocytopenia when taking Fondaparinux sodium? *

What are other drugs people take besides Fondaparinux sodium? *

What are other side effects people have besides Heparin-induced thrombocytopenia? *

Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 20.93%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 18.60%
Thrombocytopenia (decrease of platelets in blood): 6 people, 13.95%
International Normalised Ratio Increased: 6 people, 13.95%
Acute Kidney Failure: 4 people, 9.30%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 4 people, 9.30%
Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 3 people, 6.98%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 6.98%
Haematuria (presence of blood in urine): 3 people, 6.98%
Haemorrhage (bleeding): 3 people, 6.98%

What are the existing conditions these people have? *

Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 11.63%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 9.30%
Maternal Therapy To Enhance Foetal Lung Maturity: 3 people, 6.98%
High Blood Pressure: 3 people, 6.98%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 6.98%
Cardiac Valve Disease (heart valve disease): 3 people, 6.98%
Cardiac Failure Congestive: 3 people, 6.98%
Bleeding Disorders: 2 people, 4.65%
Post Procedural Complication: 1 person, 2.33%
Itching: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fondaparinux sodium and have Heparin-induced thrombocytopenia?

- Check whether Heparin-induced thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fondaparinux sodium:

Fondaparinux sodium (940 reports)

Browse all side effects of Fondaparinux sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heparin-induced thrombocytopenia:

Heparin-induced thrombocytopenia (391 drugs)

Browse all the conditions that are associated with Heparin-induced thrombocytopenia:

Heparin-induced thrombocytopenia (550 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Fondaparinux sodium) and Fondaparinux sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.